Protalix BioTherapeutics (PLX) Pension (2010 - 2026)
Protalix BioTherapeutics (PLX) posted Pension of $671000.0 for Q1 2026, up 1.51% on a QoQ basis from $661000.0 in Q4 2025, and up 21.78% year-over-year from $551000.0 in Q1 2025.
Analysis
Protalix BioTherapeutics (PLX) Pension (2010 - 2026) Analysis & Trends
Protalix BioTherapeutics has reported Pension for 17 years, with the latest figure at $671000.0 in Q1 2026.
- On a quarterly basis, Pension rose 21.78% year-over-year to $671000.0 in Q1 2026; TTM through Mar 2026 was $671000.0, a 21.78% increase from a year earlier, with the FY2025 full-year figure at $661000.0, up 18.25% from the prior year.
- Pension was $671000.0 for Q1 2026 at Protalix BioTherapeutics, up from $661000.0 in the prior quarter.
- The five-year high for Pension was $2.5 million in Q1 2022, with the low at $551000.0 in Q1 2025.
- Average Pension over 5 years is $1.1 million, with a median of $714000.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Pension sank 56.52% in 2023, then increased 21.78% in 2026.
- Over 5 years, Pension stood at $1.6 million in 2022, then plunged by 56.52% to $714000.0 in 2023, then decreased by 21.71% to $559000.0 in 2024, then grew by 18.25% to $661000.0 in 2025, then gained by 1.51% to $671000.0 in 2026.
- The last three Pension figures came in at $671000.0 (Q1 2026), $661000.0 (Q4 2025), and $631000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Protalix BioTherapeutics | 218.36 Mn | 177.71 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 671,000.00 |
| Dec 31, 2025 | 661,000.00 |
| Sep 30, 2025 | 631,000.00 |
| Jun 30, 2025 | 615,000.00 |
| Mar 31, 2025 | 551,000.00 |
| Dec 31, 2024 | 559,000.00 |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 712,000.00 |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 2.35 Mn |
| Jun 30, 2021 | 2.30 Mn |